Albuquerque, NM, United States of America

John O′Rourke

This inventor holds 1 USPTO granted patent. Top assignee: Agilvax Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John O′Rourke. Retrieved from https://idiyas.com/inventor/john-orourke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John O′Rourke: Innovator in Therapeutic Compositions

Introduction

John O′Rourke is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of therapeutic compositions, particularly through his work on xCT antibodies. His innovative approach has led to the development of a patent that holds promise for medical applications.

Latest Patents

John O′Rourke holds a patent for "Compositions and methods related to xCT antibodies." This patent focuses on therapeutic compositions that utilize xCT specific antibodies, showcasing his commitment to advancing medical science. He has 1 patent to his name, reflecting his dedication to innovation in this area.

Career Highlights

O′Rourke is currently associated with Agilvax Inc., a company that specializes in developing therapeutic solutions. His role at Agilvax Inc. allows him to work on cutting-edge research and contribute to the advancement of healthcare technologies.

Collaborations

Throughout his career, John O′Rourke has collaborated with talented individuals such as Federica Pericle and Federica Cavallo. These partnerships have enhanced his research efforts and fostered a collaborative environment for innovation.

Conclusion

John O′Rourke is a distinguished inventor whose work on xCT antibodies has the potential to impact therapeutic compositions significantly. His contributions to Agilvax Inc. and collaborations with other professionals highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…